Psychosis, Schizophrenia
Conditions
Interventions
2:Wait-list control
Sponsors
Kowloon Hospita
Eligibility
Sex/Gender
All
Age
16 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) a current persecutory delusion as defined by Freeman and Garety (2000); 2) scoring at least three on the conviction scale of the PSYRATS (Haddock, McCarron, Tarrier & Faragher, 1999); 3) that the delusion has persisted for at least three months; 4) a clinical diagnosis of schizophrenia, schizoaffective disorder or delusional disorder (that is, diagnosis of non-affective psychosis (F2) in the International Classification of Diseases and Diagnostic and Statistical Manual V); 5) a clinically significant level of worry, as indicated by scores above 44 on the Penn State Worry Questionnaire (Molina & Borkovec, 1994; Zhong, Wang, Li & Liu, 2009); 6) aged between 16 and 65 years; 7) where major changes in medication are being made, entry to the study would not occur until at least a month after stabilization of dosage. It should be noted that we will be seeing patients when the main treatment for delusions, neuroleptic medication, has generally been tried at length and their delusions are relatively stable (persistent).
Exclusion criteria
Exclusion criteria: 1) a primary diagnosis of alcohol dependency, substance dependency, or personality disorder; 2) organic syndrome or learning disability; 3) a command of spoken Chinese inadequate for engaging in therapy; 4) currently having individual cognitive behavioral therapy (though previous CBT experience is not an exclusion).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Penn State Worry Questionnaire (PSWQ);Psychotic Symptoms Rating Scale - Delusions; | — |
Countries
China
Contacts
Public ContactTing Ka Tsun
Kowloon Hospita
Outcome results
None listed